Interhospital Conference History ผู้ป่วยเด็กชายไทยอายุ 11 ปี ภูมิลาเนา จ.กรุ งเทพฯ Chief Complaint : รับมารักษาต่ อด้ วยเรื่องก้ อนบริเวณ ต่ อมทอลซิลด้ านซ้ าย 4 เดือน PTA Present Illness 4 เดือน PTA ผู้ป่วยไปรั กษาที่โรงพยาบาลเอกชนด้ วย เรื่อง ไข้ เจ็บคอ ได้ รับการวินิจฉัยว่ าต่ อมทอลซิลด้ านซ้ าย โต และอักเสบ แพทย์ ให้ การรักษาโดยการนอน โรงพยาบาล ให้ IV antibiotics, Left tonsillectomy 1 เดือนPTAแพทย์ นัดติดตามอาการตรวจพบว่ าก้ อนโต ขึน้ ไม่ มีอาการผิดปกติอย่ างอื่น ผล pathology – no malignancy จึงส่ งมารับการรักษาต่ อที่โรงพยาบาลจุฬา Past history : no underlying disease no history of drug allergy Family history : no malignancy Physical Examination GA: A Thai boy, good consciousness, well co-operative HEENT: pink conjunctiva, anicteric sclera Irregular mass below left tonsillar fossa, mass invaded posterior pillar and posterior pharyngeal wall, invade valleculae, but abutted epiglottis LN : impalpable Heart: regular, normal S1S2, no murmur Lungs: clear both lungs Abd: normoactive, no hepatosplenomegaly Investigation CBC Hb 11.6g/dl, Hct 35.7%, WBC 5,680 cells.mm3 (N59.9%, L32.9%, M4.2%, E 2.5%, B0.5%), Plt 200,000 cells/mm3 Blood chemistry BUN 12 mg/dl, Cr 0.53mg/dl Electrolyte: Na 138 mmol/L, K 4.7mmol/L, Cl 99 mmol/L, CO2 28 mmol/L TB 0.23 mg/dl, DB 0.02 mg/dl, SGOT 19mg/dl, SGPT 22mg/dl, ALP 194 U/L PROBLEM LISTS INVESTIGATION Tonsillar Biopsy Management Intraoral biopsy (28/04/52) Finding: Irregular mass at left tonsillar fossa, invaded posterior pillar, posterior pharyngeal wall, valleculae, abutted epiglottis Operation: partial excision about 50% by electrocautery Pathological Report Pathology Report Section of mucosa show vascular lesion infiltrating in underlying stroma. There are lined by plump endothelial cells witch have round to spindle nuclei, vascular chromatin, distinct nuclei and moderate amount of eosinophilic cytoplasm. Mitoses are frequently seen. Intervening stroma reveals hyalinization. Hemorrhage and many chronic and acute inflammatory cells infiltrate are observed. Covering mucosa display focal ulcer with fibrinous exudate and acute inflammatory cells infiltrate. Pseudoepitheliomatous hyperplasia is occationally noted. Hemangioendothelioma Progression ENT consult Tumor conference Tumor conference suggest MRI ก่ อน plan management เพิ่มเติม PET/CT and MRI PET/CT Report PET/CT (03/07/52) A 2.1x2.2 cm hypermatabolic irregular rim enhancing mass with central hypodensity at left palatine tonsillar fossa, consistent with history of hamangioendothelioma. This is possible residual disease Mild focal bulging medical contour of right palatine tonsil without definite abnormal enhancing area, showing homogeneous FDG accumulation, small focal lesion cannot be excluded. Tissue diagnosis is recommended. PET/CT Report Multiple hypermetabolic bilateral cervical lymph nodes (more on the left), likely nodal metastases. Multiple pulmonary nodules, probably pulmonary metastases. Multiple small hypermetabolic poorly osteolytic and nonosteolytic lesion, probably inhomogeneous marrow activity in child or foci of marrow infiltration. Correlation with other imaging modality such as bone scan is recommended Bone Scan Bone scan (17/08/52) Bone lesion at skull is corresponding with multiple geographic lytic lesions without sclerotic rim and some blastic lesions in diploic space of bilateral parietal bone, likely bone metastases. Bone lesion at C2 vertebral body, pelvic rim, right acetabulum, head, proximal, mid shaft and distal right femur, likely due to bone metastases as correlated with lytic lesion seen on PET/CT. X-Ray Management Due to PET/CT found multiple small hypermetabolic poorly osteolytic and non-osteolytic lesion, suspected bone metastases consult orthopaedics 23/7/52 Excision Bone at Right iliac, right proximal tumor Pathological report of Bone Biopsy Pathology Report Right iliac bone biopsy (23/07/52) Section show fragments of bony tissue and marrow element. Few pieces of bone reveal proliferation of blood vessels with occasionally lined by round to spindleshaped cells. Cells have round nuclei, fine chromatin, visible nucleoli Immunohistochemistry: epithelioid hemangioendothelioma Pathology Report Right proximal femur : no definite vascular tumor Impression : Gorham disease Progression 03/08/52 Start Radiotherapy at tonsils and lymph node 70 Gy 06/08/52 รับ consult at OPD ผู้ป่วยมีปัญหาเรื่องปวดที่ขา ข้ างขวาตัง้ แต่ ต้นขาถึงปลายขา ไม่ มีปวดบริเวณอื่น CBC: Hb 8.8 g/dl , WBC11,800 cells/mm 3 (N 78.3 %, L14.9 %, M3.6% , E2.9% , B0.3% ), Platelet 122,000 cells/mm 3 LD-PRC 300 ml IV drip in 3 hour Progression 7/8/52 CBC: Hb 11 g/dl , WBC 9,850 /mm 3 (N 66 %, L21 %, M 3% , E 7% , AL 3% ), Platelet 104,000 /mm 3 PTT 36.8 sec [30.4] PT 15.4 sec [13.4] Fibrinogen 641 mg/dl D-dimer 0.2 mcg/dl [< 0.3] 10/08/52 OPD Follow up ผู้ป่วยยังมีอาการปวดขาไม่ ดขี นึ ้ Bonefos (800) 2 cap oral OD เช้ า Progression 20/08/52 OPD Follow up, ปวดขามากโดยเฉพาะที่ บริเวณน่ อง, ซีดลง admit for further investigation Investigation : plain X-ray leg [right], นัด U/S right leg Consult pain: MO IV prn for pain Blood component as needed Continue Bonefos Continue Radiation Progression Follow up Lab CBC: Hb 10.1g/dl , WBC 4,360 cells/mm3 (N76%, L12%, M5%, E6%, AL1%), Plt 62,000cells/mm3 Fibrinogen = 4.66 G/L (1.7-4.0) D-dimer Vidas =3,322 ng/ml (<500) Ultrasound Ultrasonography of the right calf (26/08/52) Normal attenuation of muscles and subcutaneous tissue of right calf. No fluid or space taking lesion within right calf is observed. The color Doppler ultrasound show on evidence of hypervascularity or abnormal vascular formation within right calf. Progression 25/8/52 Start systemic treatment: Vinblastion, Prednisolone หลัง start systemic treatment ได้ 2 wk, อาการปวดลดลง และปวดห่ างมากขึน้ Continue systemic treatment และสามารถcontrol painได้ ด้ วยยากิน D/C 15/9/52 then F/U as OPD case Gorham’s Disease Dipak at el, Clinical Medicine & Research, Volume 3, Number 2: 65-74 A rare disorder characterized by proliferation of vascular channels that results in destruction and resorption of osseous matrix. There have been fewer than 150 cases reported in the literature. Etiology of Gorham’s disease remains poorly understood The pathological process is the replacement of normal bone by an aggressively expanding but non-neoplastic vascular tissue similar to a hemangioma or lymphangioma. Wildly proliferating neovascular tissue causes massive bone loss. No evidence of a malignant, neuropathic, or infectious component involved in the causation of this disorder. Clinical presentation The clinical presentation of Gorham’s disease is variable and depends on the site of involvement. Gorham’s disease may complain of dull aching pain or insidious onset of progressive weakness.In some cases, pathologic fracture often leads to its discovery. Clinical presentation Gorham’s disease can involve men or women and any age group Although most cases are discovered before the age of 40 years. No familial predisposition has been found. The process may affect the appendicular or the axial skeleton. The shoulder and the pelvis are the most common sites. Treatment The medical treatment for Gorham’s disease includes radiation therapy, anti-osteoclastic medications (bisphosphonates), and alpha-2b interferon. Surgical treatment options include resection of the lesion and reconstruction using bone grafts and/or prostheses. Treatment Radiation therapy are used for management of patients who have large, symptomatic lesions with long-standing, disabling functional instability. Definitive radiation therapy in moderate doses (40-45 Gy in 2 Gy fractions) appears to result in a good clinical outcome with few long-term complications. Treatment In general, no single treatment modality has proven effective in arresting the disease. The prognosis for patients with Gorham’s disease is generally good unless vital structures are involved. CASE ผู้ป่วยชายอายุ 20 ปี ภูมิลาเนา จ. แพร่ ผู้ป่วยมีอาการขาซ้ ายบวมเป็ น ๆ หาย ๆ ตัง้ แต่ อายุ 1 ปี 6 เดือน โดยบวมบริเวณสะโพกมาที่หวั เข่ า ไม่ แดงไม่ ร้อน X-ray, U/S doppler, CT ปกติดี อายุ 9 ปี ผู้ป่วยเริ่มมีปื้นแดงขึน้ ที่บริเวณต้ นขาซ้ ายและ สะโพกซ้ ายจึงมารักษาที่โรงพยาบาลจุฬาลงกรณ์ PE: multiple discrete purplish nodules on skin covering, swelling at both inguinal area, left buttock, left thigh, back CBC : Hb 12.6 g%, WBC 6,000 /mm3 [N 56%, L 28 %, atypical L 13%, Mo 3 %] platelet 349,000 /mm3 PT 13.1 sec [11.3], PTT 38.9 sec [33.3] Impression :Kasabach Meritt syndrome Treatment กันยายน 2541- พฤศจิกายน 2542 - Prednisolone + Interferon alpha ตุลาคม 2542- มกราคม 2544 - Vincristine clinical improve, platelet count and coagulogram ปกติ พฤษภาคม 2552 ผู้ป่วยเริ่มมีปื้นสีแดงขึน้ มาใหม่ และมี เลือดออกไม่ หยุดบริเวณ lesion ร่ วมกับมีเลือดออกตาม ไรฟั น จึงมาโรงพยาบาล ระหว่ าง admission ผู้ป่วยมี ปั ญหา hemothorax both lungs, compression fracture at T12 and multiple osteolytic lesion at spine and rib Treatment vincristine weekly [total 7 doses] vinblastine INF alfa2b [ 45 doses] Radiation 10 fraction THANK YOU FOR YOUR ATTENTION A case report of epithelioid hemangioendothelioma metastasizing to the tonsil A 40-year-old man admitted for right throat pain he underwent radical surgery. Epithelioid hemangioendothelioma was first diagnosed Lung specimens at open biopsy 4 years earlier showed the same histological features indicating he had had epithelioid hemangioendothelioma lesion since that time. We assumed this epithelioid hemangioendothelioma had originated in the lung and metastasized to the right tonsil Nippon Jibiinkoka Gakkai Kaiho. 2002 Sep;105(9):937-40. Epithelioid hemangioendothelioma is an extremely rare, difficult-to-diagnose vascular tumor mainly originating from the lung or liver. Primary tumors in the head and neck are very rare Nippon Jibiinkoka Gakkai Kaiho. 2002 Sep;105(9):937-40. Differential Diagnosis for Tonsillar hypertrophy Infectious Disorders (Specific Agent) Infectious mononucleosis Infected organ, Abscesses Pharyngitis Adenoiditis, acute Tonsillitis/exudative, acute Tonsillitis, chronic Neoplastic Disorders Tonsil lymphosarcoma Tonsil, Lymphoepithelioma Metabolic, Storage Disorders Tangier's disease Hereditary, Familial, Genetic Disorders Lipodystrophy, generalized Reference to Organ System Adenoid hypertrophy Tonsillar hypertrophy syndrome